Empagliflozin protective effects against cisplatin-induced acute nephrotoxicity by interfering with oxidative stress and inflammation in Wistar rats

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  2024-04-21

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/s00210-024-03088-6PMID 38643451
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protective effects of sitagliptin on methotrexate-induced nephrotoxicity in rats

  2023cited by this paper
• Protective effects of empagliflozin on methotrexate induced hepatotoxicity in rats.

  2023cited by this paper
• Protective effects of empagliflozin on testicular injury induced by torsion/detorsion in adult male rats.

  2023cited by this paper
• Biochemical and histopathological evidence for beneficial effects of Empagliflozin pretreatment on acetic acid-induced colitis in rats

  2023cited by this paper
• Cisplatin in Ovarian Cancer Treatment—Known Limitations in Therapy Force New Solutions

  2023cited by this paper
• Protective effects of metformin against aluminum phosphide-induced acute hepato-renal damage in rats: An experimental approach.

  2022cited by this paper
• Cisplatin for cancer therapy and overcoming chemoresistance

  2022cited by this paper
• Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity

  2022cited by this paper
• Empagliflozin-Metformin Combination Has Antioxidative and Anti-Inflammatory Properties that Correlate with Vascular Protection in Adults with Type 1 Diabetes

  2022cited by this paper
• Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson’s disease in rats

  2022cited by this paper
• Antioxidant Roles of SGLT2 Inhibitors in the Kidney

  2022cited by this paper
• Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study.

  2022cited by this paper
• Cisplatin Nephrotoxicity: Novel Insights Into Mechanisms and Preventative Strategies.

  2022cited by this paper
• 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023.

  2022cited by this paper
• Cisplatin in Cancer Treatment.

  2022cited by this paper
• Empagliflozin reduces kidney fibrosis and improves kidney function by alternative macrophage activation in rats with 5/6-nephrectomy.

  2022cited by this paper
• Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-κB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways

  2021cited by this paper
• INNATE IMMUNITY IN NEPHROTOXIC ACUTE KIDNEY INJURY.

  2019cited by this paper
• Pre-treatment with Empagliflozin ameliorates Cisplatin induced acute kidney injury by suppressing apoptosis.

  2019cited by this paper
• Docetaxel plus cisplatin and S-1 versus cisplatin and S-1 in patients with advanced gastric cancer (JCOG1013): an open-label, phase 3, randomised controlled trial.

  2019cited by this paper
• The SGLT2 Inhibitor Empagliflozin Ameliorates the Inflammatory Profile in Type 2 Diabetic Patients and Promotes an Antioxidant Response in Leukocytes

  2019cited by this paper
• Cisplatin-Induced Nephrotoxicity in Rats: Modulatory Role of Simvastatin and Rosuvastatin against Apoptosis and Inflammation. -

  2018influential reference
• Role of food-derived antioxidants against cisplatin induced-nephrotoxicity.

  2018cited by this paper
• Effects of quercetin on methotrexate-induced nephrotoxicity in rats

  2017cited by this paper
• Effect of weight loss on renal function in overweight and obese patients with heart failure.

  2017cited by this paper
• A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity.

  2017cited by this paper
• Pharmacotherapeutic options for treating adverse effects of Cisplatin chemotherapy

  2016cited by this paper
• Incidence of cisplatin-induced nephrotoxicity and associated factors among cancer patients in Indonesia.

  2015cited by this paper
• Curcumin ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in mice.

  2013cited by this paper
• A model for prediction of cisplatin induced nephrotoxicity by kidney weight in experimental rats

  2013cited by this paper
• Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats.

  2012cited by this paper
• Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research †

  2012cited by this paper
• Markers of renal function tests

  2010cited by this paper
• Mechanisms of Cisplatin Nephrotoxicity

  2010cited by this paper
• Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria

  2007cited by this paper
• Cisplatin nephrotoxicity: molecular mechanisms.

  2003cited by this paper
• Technical Report Abstracts

  1993cited by this paper
• Cellular and extracellular myeloperoxidase in pyogenic inflammation.

  1982cited by this paper

• Anti-diabetic drugs: a novel therapeutic approach against cisplatin-induced kidney injury, a mechanistic review of preclinical studies

  2026cites this paper
• Empagliflozin mitigates doxorubicin-induced nephrotoxicity by modulating sirtuin 1, nuclear factor-κB/tumor necrosis factor-α, and cleaved caspase-3 pathways without compromising its cytotoxic efficacy.

  2026cites this paper
• Persisting blood–brain barrier disruption following cisplatin treatment in a mouse model of chemotherapy-associated cognitive impairment

  2025cites this paper
• The reno-protective effect of Empagliflozin against carbon tetrachloride (CCl4)-induced nephrotoxicity in mice halting JNK/MKK4/NRF2/NF-KB pathway.

  2025cites this paper
• Nephroprotective Potential of Lyophilized Grewia asiatica Powder Against Renal Biomarkers and Inflammation In Vivo

  2025cites this paper
• Protective effect of empagliflozin against paracetamol-induced acute kidney injury through modulation of AMPK/SIRT1/PGC-1α pathway in experimental mice.

  2025cites this paper
• Immunological mediators in the causal relationship between latent autoimmune diabetes in adults and breast cancer: A Mendelian randomization analysis

  2025cites this paper
• Antioxidant Effects of SGLT2 Inhibitors on Cardiovascular–Kidney–Metabolic (CKM) Syndrome

  2025cites this paper
• The Effect of Dapagliflozin, a Sodium–Glucose Co-Transporter 2 Inhibitor, on Vancomycin-Induced Nephrotoxicity in Rats

  2025cites this paper
• Empagliflozin attenuates sorafenib-promoted renal ferroptosis and inflammation by targeting cyclooxygenase-2/prostaglandin E2 axis.

  2025cites this paper
• Interactive impacts of heat stress and microplastics contamination on the growth and biochemical response of wheat (Triticum aestivum) and maize (Zea mays) plants

  2025cites this paper
• Evaluation of Ototoxic Effects of Cisplatin in a Rat Model: A Dose–Response Study

  2025cites this paper
• The toxicity of cisplatin derives from effects on renal organic ion transporters expression and serum endogenous substance levels.

  2024cites this paper
• Anti-Diabetic Therapies and Cancer: From Bench to Bedside

  2024cites this paper